Well, it is all assumptions of course. But 20% success was fine because several years ago one analysis showed expected success for Rett trials is around 10-15%. Market is small enough to know its specifics and make correct assumptions. What changed is the success rate and synergy spill-over to other trials.. both pointing upward...